Search Ontology:
ChEBI
idelalisib
- Term ID
- CHEBI:82701
- Synonyms
-
- 5-Fluoro-3-phenyl-2-((S)-1-(9H-purin-6-ylamino)-propyl)-3H-quinazolin-4-one
- 5-fluoro-3-phenyl-2-[(1S)-1-(3H-purin-6-ylamino)propyl]quinazolin-4(3H)-one
- CAL-101
- GS-1101
- ZYDELIG
- Definition
- A member of the class of quinazolines that is 5-fluoro-3-phenylquinazolin-4-one in which the hydrogen at position 2 is replaced by a (1S)-1-(3H-purin-6-ylamino)propyl group. used for for the treatment of refractory indolent non-Hodgkin's lymphoma and relapsed chronic lymphocytic leukemia.
- References
-
- CAS:870281-82-6
- Drug_Central:4878
- LINCS:LSM-1205
- PMID:24376763
- PMID:24450857
- PMID:24450858
- PMID:24463402
- PMID:24615776
- PMID:24615777
- PMID:24615778
- PMID:24619588
- PMID:24659719
- PMID:24795031
- PMID:25093123
- PMID:25187123
- PMID:25274697
- Reaxys:12464214
- Wikipedia:Idelalisib
- Ontology
- ChEBI ( EBI )
- is a type of
-
- has_role
-
Phenotype
Phenotype resulting from idelalisib
Phenotype where environments contain idelalisib
Phenotype modified by environments containing idelalisib
Human Disease Model